Byrnes Michael 4
4 · eFFECTOR Therapeutics, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Byrnes Michael
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-20+235,541→ 235,541 totalExercise: $1.49Exp: 2032-06-19→ Common Stock (235,541 underlying)
Footnotes (1)
- [F1]The stock option vests 50% on June 20, 2023, and in 12 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.